Journal
ANTIBIOTICS-BASEL
Volume 11, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/antibiotics11121720
Keywords
nontuberculous mycobacteria; Mycobacterium avium complex; Mycobacterium abscessus; susceptibility
Categories
Ask authors/readers for more resources
Nontuberculous mycobacterial (NTM) infections pose treatment challenges and limited data exists on treatment outcomes in U.S. adults. This retrospective study analyzed a cohort of NTM-infected adults and found Mycobacterium avium intracellulare complex and Mycobacterium abscessus to be the most prevalent isolates. Only 35% of patients received treatment, with a favorable outcome observed in 61.4% of cases. Multiple changes in antimicrobial therapy were associated with unfavorable outcomes, highlighting the importance of interdisciplinary collaboration to improve treatment outcomes in NTM infections.
Nontuberculous mycobacterial (NTM) infections present a treatment challenge for clinicians and patients. There are limited data about current susceptibility patterns and treatment outcomes in U.S. adults. This was a 10-year, single-center, retrospective, observational cohort study of adults with a positive NTM culture and clinical suspicion of infection between 1 January 2010 and 30 June 2020. The primary objective was to identify predictors for favorable treatment outcomes. Key secondary objectives were characterization of NTM epidemiology, susceptibility profiles, and safety and tolerability of treatment, including the proportion of subjects with an antimicrobial change and the reasons for the change. Of 250 subjects diagnosed with NTM infection, the most prevalent NTM isolates were Mycobacterium avium intracellulare complex (66.8%) followed by Mycobacterium abscessus (17.6%). Antimicrobial susceptibility data were available for 52.4% of the cohort (45.8% slow growers; 54.2% rapid growers). Only 88 (35%) subjects received treatment with evaluable clinical outcomes. The proportion of subjects with a favorable outcome was 61.4%. More subjects in the unfavorable outcome group experienced a change in antimicrobial therapy (73.5% vs. 51.9%, p = 0.043). The most common reason for antimicrobial change was adverse drug events (n = 36, 67.9%). In the regression model, private insurance was associated with a favorable outcome, whereas having multiple antimicrobial changes was associated with an unfavorable outcome. The complexity of NTM treatment and high incidence of medication-related issues suggest the necessity of interdisciplinary collaboration to improve overall treatment outcomes in NTM infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available